Doug Forsyth
Net worth: 18 M $ as of 31/07/2026
Net worth: 18 M $ as of 31/07/2026
Douglas Gorman Forsyth is currently Director at Ticketsauce, Inc. and Independent Director at Inhibrx Biosciences, Inc. since 2024.
Formerly, Mr. Forsyth was Managing Director at Nicholas-Applegate Capital Management from 1994 to 2010, Managing Director at Virtus Equity & Convertible Income Fund, Director at LiveStyle, Inc., Independent Director at Sanofi AATD, Inc. from 2018 to 2024, Principal at AEGON USA LLC from 1991 to 1993, Vice President at Nicholas-Applegate Convertible & Income Fund, and MD, Portfolio Manager & CIO of US Income & Growth at Allianz Global Investors U.S.
LLC from 2019 to 2022.
Education includes undergraduate studies at the University of Iowa.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.53% | 03/06/2026 | 2,24,564 ( 1.53% ) | 18 M $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
Ticketsauce, Inc. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Director/Board Member | 30/05/2024 |
Allianz Global Investors U.S. LLC
Allianz Global Investors U.S. LLC Investment ManagersFinance AllianzGI US manages client portfolios (directly or through model delivery and wrap fee programs) using traditional and systematic processes across various investment strategies. The firm offers an array of US equity strategies that vary across style and market-cap ranges. Their high yield bond and convertibles strategies employ a fundamental bottom-up process that seeks the early identification of high yield issuers that exhibit the potential for improving fundamental characteristics. AllianzGI US employs rigorous fundamental research and capital structure analysis to construct portfolios that consist of the best companies from a risk/return standpoint. They also offer alternative investment strategies that are designed to achieve absolute return, alpha enhancement and beta hedging. | Head-Equity Investments | 01/03/2022 |
Nicholas-Applegate Capital Management
Nicholas-Applegate Capital Management Investment ManagersFinance Nicholas-Applegate Capital Management employs a forward-thinking, change-focused investment philosophy to create domestic and international portfolios across fundamental and systematic equity, income and growth strategies. The firm's investment approach seeks to identify points of inflection that could lead to strong price appreciation and to invest in a timely manner to maximize return potential. The firm's range of investment strategies include domestic, global, international and specialty portfolios. Each portfolio follows one of two approaches: traditional or model-driven (systematic). Nicholas-Applegate tends to invest in the stocks of companies in the electronic technology, health technology, technology services, consumer non-durables and finance sectors. The firm invests globally, across all market-caps. Nicholas-Applegate maintains a medium turnover rate. | Portfolio Manager-Equities | 30/04/2010 |
AEGON USA LLC
AEGON USA LLC Insurance Brokers/ServicesFinance Provides insurance brokerage services | Corporate Officer/Principal | 31/12/1993 |
| SFX ENTERTAINMENT INC | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
AEGON USA LLC
AEGON USA LLC Insurance Brokers/ServicesFinance Provides insurance brokerage services | Finance |
Nicholas-Applegate Capital Management
Nicholas-Applegate Capital Management Investment ManagersFinance Nicholas-Applegate Capital Management employs a forward-thinking, change-focused investment philosophy to create domestic and international portfolios across fundamental and systematic equity, income and growth strategies. The firm's investment approach seeks to identify points of inflection that could lead to strong price appreciation and to invest in a timely manner to maximize return potential. The firm's range of investment strategies include domestic, global, international and specialty portfolios. Each portfolio follows one of two approaches: traditional or model-driven (systematic). Nicholas-Applegate tends to invest in the stocks of companies in the electronic technology, health technology, technology services, consumer non-durables and finance sectors. The firm invests globally, across all market-caps. Nicholas-Applegate maintains a medium turnover rate. | Finance |
Nicholas-Applegate Convertible & Income Fund
Nicholas-Applegate Convertible & Income Fund Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allianz Global Investors U.S. LLC
Allianz Global Investors U.S. LLC Investment ManagersFinance AllianzGI US manages client portfolios (directly or through model delivery and wrap fee programs) using traditional and systematic processes across various investment strategies. The firm offers an array of US equity strategies that vary across style and market-cap ranges. Their high yield bond and convertibles strategies employ a fundamental bottom-up process that seeks the early identification of high yield issuers that exhibit the potential for improving fundamental characteristics. AllianzGI US employs rigorous fundamental research and capital structure analysis to construct portfolios that consist of the best companies from a risk/return standpoint. They also offer alternative investment strategies that are designed to achieve absolute return, alpha enhancement and beta hedging. | Finance |
Virtus Equity & Convertible Income Fund
Virtus Equity & Convertible Income Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
LiveStyle, Inc.
LiveStyle, Inc. Media ConglomeratesConsumer Services Operates live events, festivals and nightclubs | Consumer Services |
Inhibrx, Inc.
Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
Ticketsauce, Inc. |
Select your edition
All financial news and data tailored to specific country editions